ResearcherUniversity of SouthamptonActive in the last 2 years

Umar H.K. Niazi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7176-8883; OpenAlex author ID A5082507956. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma Co-author DOI 10.2139/ssrn.7472539 ↗
Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17071150 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Declan McDonnell · 2 shared papers, 2025–2026 · strength 0.57
- Paper Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma DOI 10.2139/ssrn.7472539 ↗
- Paper Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers17071150 ↗
Paul R. Afolabi · 2 shared papers, 2025–2026 · strength 0.57
- Paper Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma DOI 10.2139/ssrn.7472539 ↗
- Paper Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers17071150 ↗
Zaed Z. R. Hamady · 2 shared papers, 2025–2026 · strength 0.57
- Paper Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma DOI 10.2139/ssrn.7472539 ↗
- Paper Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers17071150 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.